Oncolytics Biotech receives Nasdaq delisting notice for bid price below $1.00

ONCOLYTICS BIOTECH INC

Received Nasdaq letter on July 20, 2026, for non-compliance with $1.00 minimum bid price rule.
Common stock closed below $1.00 for 30 consecutive business days; ticker ONCY remains listed.
180-day compliance period ends January 19, 2027; must close at $1.00+ for 10 consecutive days.
If not cured, may qualify for additional 180-day period if other listing standards are met.
Company will monitor bid price and assess options; no assurance of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.